Biomarker modelling of early molecular changes in Alzheimer's disease.

about

Biomarkers in dementia: clinical utility and new directions Dissecting IWG-2 typical and atypical Alzheimer's disease: insights from cerebrospinal fluid analysis.

P2860

Q27007086-1A86705B-6B14-4A5B-8508-25B9D6EBD084 Q39342351-B829B214-D180-4BBD-B0B5-D8514F218AF7

P2860

Biomarker modelling of early molecular changes in Alzheimer's disease.

Item

http://www.wikidata.org/entity/Q38166669

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Biomarker modelling of early molecular changes in Alzheimer's disease.

@en

type

Item

label

Biomarker modelling of early molecular changes in Alzheimer's disease.

@en

prefLabel

Biomarker modelling of early molecular changes in Alzheimer's disease.

@en

P1476

Biomarker modelling of early molecular changes in Alzheimer's disease.

@en

P2093

Catherine F Slattery

http://www.w3.org/2001/XMLSchema#string

Jamie Toombs

http://www.w3.org/2001/XMLSchema#string

Jonathan M Schott

http://www.w3.org/2001/XMLSchema#string

Ross W Paterson

http://www.w3.org/2001/XMLSchema#string

P2860

TREM2 Variants in Alzheimer's Disease

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

Quantitative modelling of amyloidogenic processing and its influence by SORLA in Alzheimer's disease

Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

Testing the right target and right drug at the right stage

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Searching for a baseline: functional imaging and the resting human brain

Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease

P2888

s40291-013-0069-9

P304

213-227

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40291-013-0069-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Henrik Zetterberg

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1029250520

http://www.w3.org/2001/XMLSchema#string

P698

24281842

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

biomarker

Biomarker modelling of early molecular changes in Alzheimer's disease.

about

P2860

P2860

Biomarker modelling of early molecular changes in Alzheimer's disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921